India has never pursued an offensive bio weapons programme

In 2003, the United States Congressional Research Service asserted that there is a danger that India may develop a bio weapons programme. It claimed that 'India is believed to have an active......

Will Sudhir Valia, Suraksha's 'deal maker' manage to bag Jaypee Infra?

Suraksha started by funding developers for projects, and then evolved into realty angel investing. Dev Chatterjee reports. IMAGE: Suraksha Smart City - Vasai-Virar's biggest township under......

Coronavirus crisis pushes India to work on drug security

The current crisis has forced the government to announce measures to ensure that India becomes self-sustaining for any kind of bulk drug.The government says India will not depend on any other......

2018: Year of reckoning for India Inc

A glance back at some important ups and down India Inc faced in 2018. Year End Specials   Kindly click on the image below to view the relevant story. #1 How PNB scam effected consumer......

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

Sun Pharma’s market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013. The country’s leading drug maker......